nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—kidney cancer	0.203	1	CbGaD
Spironolactone—ABCC2—Paclitaxel—kidney cancer	0.0459	0.0887	CbGbCtD
Spironolactone—ABCB1—Temsirolimus—kidney cancer	0.0436	0.0843	CbGbCtD
Spironolactone—ABCC2—Sorafenib—kidney cancer	0.0407	0.0788	CbGbCtD
Spironolactone—ABCC2—Vinblastine—kidney cancer	0.0402	0.0778	CbGbCtD
Spironolactone—ABCC2—Vincristine—kidney cancer	0.0395	0.0765	CbGbCtD
Spironolactone—CYP2C8—Pazopanib—kidney cancer	0.0338	0.0654	CbGbCtD
Spironolactone—ABCC2—Sunitinib—kidney cancer	0.033	0.0638	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—kidney cancer	0.0247	0.0478	CbGbCtD
Spironolactone—CYP2C8—Erlotinib—kidney cancer	0.0241	0.0467	CbGbCtD
Spironolactone—ABCB1—Pazopanib—kidney cancer	0.0229	0.0443	CbGbCtD
Spironolactone—CYP2C8—Paclitaxel—kidney cancer	0.0221	0.0427	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—kidney cancer	0.0209	0.0405	CbGbCtD
Spironolactone—CYP2C8—Sorafenib—kidney cancer	0.0196	0.0379	CbGbCtD
Spironolactone—NR3C2—collecting duct of renal tubule—kidney cancer	0.0171	0.28	CbGeAlD
Spironolactone—ABCB1—Gemcitabine—kidney cancer	0.0165	0.032	CbGbCtD
Spironolactone—ABCB1—Erlotinib—kidney cancer	0.0163	0.0316	CbGbCtD
Spironolactone—ABCB1—Paclitaxel—kidney cancer	0.0149	0.0289	CbGbCtD
Spironolactone—ABCB1—Sorafenib—kidney cancer	0.0133	0.0257	CbGbCtD
Spironolactone—ABCB1—Vinblastine—kidney cancer	0.0131	0.0254	CbGbCtD
Spironolactone—ABCB1—Vincristine—kidney cancer	0.0129	0.0249	CbGbCtD
Spironolactone—ABCB1—Sunitinib—kidney cancer	0.0108	0.0208	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—kidney cancer	0.00806	0.0156	CbGbCtD
Spironolactone—NR3C2—nephron—kidney cancer	0.00759	0.125	CbGeAlD
Spironolactone—CYP11B2—renal system—kidney cancer	0.00337	0.0554	CbGeAlD
Spironolactone—NR3C1—urine—kidney cancer	0.00327	0.0536	CbGeAlD
Spironolactone—NR3C2—nephron tubule—kidney cancer	0.00164	0.0269	CbGeAlD
Spironolactone—NR3C2—renal system—kidney cancer	0.00149	0.0244	CbGeAlD
Spironolactone—NR3C2—kidney—kidney cancer	0.00144	0.0236	CbGeAlD
Spironolactone—NR3C2—cortex of kidney—kidney cancer	0.0014	0.023	CbGeAlD
Spironolactone—SHBG—gonad—kidney cancer	0.00138	0.0226	CbGeAlD
Spironolactone—NR3C2—cardiac atrium—kidney cancer	0.00133	0.0219	CbGeAlD
Spironolactone—ABCC2—nephron tubule—kidney cancer	0.00131	0.0215	CbGeAlD
Spironolactone—SLCO1A2—renal system—kidney cancer	0.00128	0.021	CbGeAlD
Spironolactone—SLCO1A2—kidney—kidney cancer	0.00123	0.0203	CbGeAlD
Spironolactone—ABCC2—renal system—kidney cancer	0.00119	0.0195	CbGeAlD
Spironolactone—ABCC2—kidney—kidney cancer	0.00115	0.0189	CbGeAlD
Spironolactone—ABCC2—cortex of kidney—kidney cancer	0.00112	0.0184	CbGeAlD
Spironolactone—AR—renal system—kidney cancer	0.0011	0.0181	CbGeAlD
Spironolactone—AR—kidney—kidney cancer	0.00107	0.0175	CbGeAlD
Spironolactone—AR—cortex of kidney—kidney cancer	0.00104	0.017	CbGeAlD
Spironolactone—AR—gonad—kidney cancer	0.000989	0.0162	CbGeAlD
Spironolactone—AR—cardiac atrium—kidney cancer	0.000988	0.0162	CbGeAlD
Spironolactone—Hydrocortisone—ANXA1—kidney cancer	0.000925	0.356	CrCbGaD
Spironolactone—CYP2C8—renal system—kidney cancer	0.000892	0.0146	CbGeAlD
Spironolactone—NR3C1—nephron tubule—kidney cancer	0.000879	0.0144	CbGeAlD
Spironolactone—CYP2C8—kidney—kidney cancer	0.000862	0.0142	CbGeAlD
Spironolactone—NR3C1—renal system—kidney cancer	0.000799	0.0131	CbGeAlD
Spironolactone—NR3C1—kidney—kidney cancer	0.000772	0.0127	CbGeAlD
Spironolactone—NR3C1—cortex of kidney—kidney cancer	0.000752	0.0123	CbGeAlD
Spironolactone—NR3C1—gonad—kidney cancer	0.000717	0.0118	CbGeAlD
Spironolactone—NR3C1—cardiac atrium—kidney cancer	0.000716	0.0117	CbGeAlD
Spironolactone—Drospirenone—BCHE—kidney cancer	0.000571	0.219	CrCbGaD
Spironolactone—Somnolence—Temsirolimus—kidney cancer	0.000526	0.00367	CcSEcCtD
Spironolactone—Muscle spasms—Everolimus—kidney cancer	0.000518	0.00362	CcSEcCtD
Spironolactone—Lethargy—Paclitaxel—kidney cancer	0.000513	0.00358	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000511	0.00357	CcSEcCtD
Spironolactone—Agranulocytosis—Dactinomycin—kidney cancer	0.000509	0.00356	CcSEcCtD
Spironolactone—Erythema multiforme—Sorafenib—kidney cancer	0.000508	0.00355	CcSEcCtD
Spironolactone—Erectile dysfunction—Vincristine—kidney cancer	0.000503	0.00352	CcSEcCtD
Spironolactone—Ill-defined disorder—Vinblastine—kidney cancer	0.000502	0.00351	CcSEcCtD
Spironolactone—Ill-defined disorder—Everolimus—kidney cancer	0.0005	0.00349	CcSEcCtD
Spironolactone—Somnolence—Pazopanib—kidney cancer	0.000495	0.00346	CcSEcCtD
Spironolactone—Erythema multiforme—Sunitinib—kidney cancer	0.000489	0.00342	CcSEcCtD
Spironolactone—Malaise—Vinblastine—kidney cancer	0.000488	0.00341	CcSEcCtD
Spironolactone—Malaise—Everolimus—kidney cancer	0.000486	0.0034	CcSEcCtD
Spironolactone—Leukopenia—Vinblastine—kidney cancer	0.000484	0.00338	CcSEcCtD
Spironolactone—Leukopenia—Everolimus—kidney cancer	0.000483	0.00337	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000481	0.00336	CcSEcCtD
Spironolactone—Rash erythematous—Doxorubicin—kidney cancer	0.000478	0.00334	CcSEcCtD
Spironolactone—Alopecia—Sorafenib—kidney cancer	0.000475	0.00332	CcSEcCtD
Spironolactone—Ataxia—Paclitaxel—kidney cancer	0.000472	0.0033	CcSEcCtD
Spironolactone—ABCB1—nephron tubule—kidney cancer	0.000471	0.00772	CbGeAlD
Spironolactone—Body temperature increased—Temsirolimus—kidney cancer	0.000468	0.00327	CcSEcCtD
Spironolactone—Erythema multiforme—Dactinomycin—kidney cancer	0.000463	0.00323	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Gemcitabine—kidney cancer	0.000458	0.0032	CcSEcCtD
Spironolactone—Alopecia—Sunitinib—kidney cancer	0.000457	0.00319	CcSEcCtD
Spironolactone—Discomfort—Vinblastine—kidney cancer	0.000455	0.00318	CcSEcCtD
Spironolactone—Renal failure—Gemcitabine—kidney cancer	0.000454	0.00317	CcSEcCtD
Spironolactone—Discomfort—Everolimus—kidney cancer	0.000453	0.00317	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.000452	0.00316	CcSEcCtD
Spironolactone—Cramp muscle—Paclitaxel—kidney cancer	0.000452	0.00316	CcSEcCtD
Spironolactone—Muscle spasms—Sorafenib—kidney cancer	0.00045	0.00314	CcSEcCtD
Spironolactone—Renal failure acute—Capecitabine—kidney cancer	0.000446	0.00312	CcSEcCtD
Spironolactone—Hypersensitivity—Temsirolimus—kidney cancer	0.000436	0.00304	CcSEcCtD
Spironolactone—Muscle spasms—Sunitinib—kidney cancer	0.000433	0.00302	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—kidney cancer	0.000433	0.00302	CcSEcCtD
Spironolactone—Thrombocytopenia—Vinblastine—kidney cancer	0.000432	0.00302	CcSEcCtD
Spironolactone—Agranulocytosis—Gemcitabine—kidney cancer	0.000431	0.00301	CcSEcCtD
Spironolactone—Thrombocytopenia—Everolimus—kidney cancer	0.000431	0.00301	CcSEcCtD
Spironolactone—ABCB1—renal system—kidney cancer	0.000428	0.00702	CbGeAlD
Spironolactone—Lethargy—Capecitabine—kidney cancer	0.000421	0.00294	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—kidney cancer	0.00042	0.00293	CcSEcCtD
Spironolactone—Leukopenia—Sorafenib—kidney cancer	0.000419	0.00293	CcSEcCtD
Spironolactone—Pruritus—Temsirolimus—kidney cancer	0.000418	0.00292	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—kidney cancer	0.000417	0.00291	CcSEcCtD
Spironolactone—Thrombocytopenia—Erlotinib—kidney cancer	0.000416	0.0029	CcSEcCtD
Spironolactone—ABCB1—kidney—kidney cancer	0.000414	0.00679	CbGeAlD
Spironolactone—Diarrhoea—Temsirolimus—kidney cancer	0.000405	0.00283	CcSEcCtD
Spironolactone—Leukopenia—Sunitinib—kidney cancer	0.000403	0.00281	CcSEcCtD
Spironolactone—ABCB1—cortex of kidney—kidney cancer	0.000403	0.00661	CbGeAlD
Spironolactone—Ill-defined disorder—Dactinomycin—kidney cancer	0.000396	0.00276	CcSEcCtD
Spironolactone—Pruritus—Pazopanib—kidney cancer	0.000394	0.00275	CcSEcCtD
Spironolactone—Erythema multiforme—Gemcitabine—kidney cancer	0.000392	0.00274	CcSEcCtD
Spironolactone—Somnolence—Everolimus—kidney cancer	0.000391	0.00273	CcSEcCtD
Spironolactone—Dizziness—Temsirolimus—kidney cancer	0.000391	0.00273	CcSEcCtD
Spironolactone—Ataxia—Capecitabine—kidney cancer	0.000388	0.00271	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—kidney cancer	0.000387	0.0027	CcSEcCtD
Spironolactone—Alopecia—Vincristine—kidney cancer	0.000387	0.0027	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—kidney cancer	0.000384	0.00268	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000384	0.00268	CcSEcCtD
Spironolactone—ABCB1—gonad—kidney cancer	0.000384	0.0063	CbGeAlD
Spironolactone—Anaphylactic shock—Sorafenib—kidney cancer	0.000382	0.00267	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—kidney cancer	0.000382	0.00266	CcSEcCtD
Spironolactone—Diarrhoea—Pazopanib—kidney cancer	0.000381	0.00266	CcSEcCtD
Spironolactone—Renal failure—Paclitaxel—kidney cancer	0.000381	0.00266	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Everolimus—kidney cancer	0.00038	0.00265	CcSEcCtD
Spironolactone—Vomiting—Temsirolimus—kidney cancer	0.000376	0.00263	CcSEcCtD
Spironolactone—Thrombocytopenia—Sorafenib—kidney cancer	0.000374	0.00261	CcSEcCtD
Spironolactone—Rash—Temsirolimus—kidney cancer	0.000373	0.0026	CcSEcCtD
Spironolactone—Dermatitis—Temsirolimus—kidney cancer	0.000373	0.0026	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000371	0.00259	CcSEcCtD
Spironolactone—Headache—Temsirolimus—kidney cancer	0.000371	0.00259	CcSEcCtD
Spironolactone—Dizziness—Pazopanib—kidney cancer	0.000368	0.00257	CcSEcCtD
Spironolactone—Alopecia—Gemcitabine—kidney cancer	0.000367	0.00256	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000366	0.00256	CcSEcCtD
Spironolactone—Gastritis—Capecitabine—kidney cancer	0.000365	0.00255	CcSEcCtD
Spironolactone—Feeling abnormal—Vinblastine—kidney cancer	0.000364	0.00254	CcSEcCtD
Spironolactone—Feeling abnormal—Everolimus—kidney cancer	0.000363	0.00253	CcSEcCtD
Spironolactone—Thrombocytopenia—Sunitinib—kidney cancer	0.00036	0.00251	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—kidney cancer	0.00036	0.00251	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—kidney cancer	0.000359	0.0025	CcSEcCtD
Spironolactone—Vomiting—Pazopanib—kidney cancer	0.000354	0.00247	CcSEcCtD
Spironolactone—Rash—Pazopanib—kidney cancer	0.000351	0.00245	CcSEcCtD
Spironolactone—Nausea—Temsirolimus—kidney cancer	0.000351	0.00245	CcSEcCtD
Spironolactone—Dermatitis—Pazopanib—kidney cancer	0.000351	0.00245	CcSEcCtD
Spironolactone—Headache—Pazopanib—kidney cancer	0.000349	0.00244	CcSEcCtD
Spironolactone—Body temperature increased—Everolimus—kidney cancer	0.000348	0.00243	CcSEcCtD
Spironolactone—Leukopenia—Vincristine—kidney cancer	0.000341	0.00238	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—kidney cancer	0.000341	0.00238	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000336	0.00235	CcSEcCtD
Spironolactone—Body temperature increased—Erlotinib—kidney cancer	0.000336	0.00234	CcSEcCtD
Spironolactone—Ill-defined disorder—Gemcitabine—kidney cancer	0.000335	0.00234	CcSEcCtD
Spironolactone—Nausea—Pazopanib—kidney cancer	0.000331	0.00231	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00033	0.0023	CcSEcCtD
Spironolactone—Erythema multiforme—Paclitaxel—kidney cancer	0.000329	0.00229	CcSEcCtD
Spironolactone—Malaise—Gemcitabine—kidney cancer	0.000326	0.00228	CcSEcCtD
Spironolactone—Hypersensitivity—Vinblastine—kidney cancer	0.000325	0.00227	CcSEcCtD
Spironolactone—Hypersensitivity—Everolimus—kidney cancer	0.000324	0.00226	CcSEcCtD
Spironolactone—Leukopenia—Gemcitabine—kidney cancer	0.000323	0.00226	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000317	0.00222	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000315	0.0022	CcSEcCtD
Spironolactone—Renal failure—Capecitabine—kidney cancer	0.000312	0.00218	CcSEcCtD
Spironolactone—Pruritus—Everolimus—kidney cancer	0.000311	0.00217	CcSEcCtD
Spironolactone—Anaphylactic shock—Vincristine—kidney cancer	0.000311	0.00217	CcSEcCtD
Spironolactone—Alopecia—Paclitaxel—kidney cancer	0.000307	0.00214	CcSEcCtD
Spironolactone—Thrombocytopenia—Vincristine—kidney cancer	0.000304	0.00213	CcSEcCtD
Spironolactone—Discomfort—Gemcitabine—kidney cancer	0.000304	0.00212	CcSEcCtD
Spironolactone—Urticaria—Sorafenib—kidney cancer	0.000303	0.00212	CcSEcCtD
Spironolactone—Diarrhoea—Vinblastine—kidney cancer	0.000302	0.00211	CcSEcCtD
Spironolactone—Body temperature increased—Sorafenib—kidney cancer	0.000302	0.00211	CcSEcCtD
Spironolactone—Diarrhoea—Everolimus—kidney cancer	0.000301	0.0021	CcSEcCtD
Spironolactone—Pruritus—Erlotinib—kidney cancer	0.0003	0.0021	CcSEcCtD
Spironolactone—Agranulocytosis—Capecitabine—kidney cancer	0.000296	0.00207	CcSEcCtD
Spironolactone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000295	0.00206	CcSEcCtD
Spironolactone—Dizziness—Vinblastine—kidney cancer	0.000292	0.00204	CcSEcCtD
Spironolactone—Dizziness—Everolimus—kidney cancer	0.000291	0.00203	CcSEcCtD
Spironolactone—Muscle spasms—Paclitaxel—kidney cancer	0.000291	0.00203	CcSEcCtD
Spironolactone—Body temperature increased—Sunitinib—kidney cancer	0.000291	0.00203	CcSEcCtD
Spironolactone—Diarrhoea—Erlotinib—kidney cancer	0.00029	0.00203	CcSEcCtD
Spironolactone—Thrombocytopenia—Gemcitabine—kidney cancer	0.000289	0.00202	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—kidney cancer	0.000288	0.00201	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—kidney cancer	0.000287	0.002	CcSEcCtD
Spironolactone—Hypersensitivity—Sorafenib—kidney cancer	0.000281	0.00197	CcSEcCtD
Spironolactone—Vomiting—Vinblastine—kidney cancer	0.000281	0.00196	CcSEcCtD
Spironolactone—Dizziness—Erlotinib—kidney cancer	0.000281	0.00196	CcSEcCtD
Spironolactone—Ill-defined disorder—Paclitaxel—kidney cancer	0.000281	0.00196	CcSEcCtD
Spironolactone—Vomiting—Everolimus—kidney cancer	0.00028	0.00195	CcSEcCtD
Spironolactone—Rash—Everolimus—kidney cancer	0.000277	0.00194	CcSEcCtD
Spironolactone—Dermatitis—Everolimus—kidney cancer	0.000277	0.00194	CcSEcCtD
Spironolactone—Headache—Vinblastine—kidney cancer	0.000277	0.00193	CcSEcCtD
Spironolactone—Headache—Everolimus—kidney cancer	0.000276	0.00192	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—kidney cancer	0.000275	0.00192	CcSEcCtD
Spironolactone—Malaise—Paclitaxel—kidney cancer	0.000273	0.00191	CcSEcCtD
Spironolactone—Lethargy—Doxorubicin—kidney cancer	0.000271	0.00189	CcSEcCtD
Spironolactone—Leukopenia—Paclitaxel—kidney cancer	0.000271	0.00189	CcSEcCtD
Spironolactone—Hypersensitivity—Sunitinib—kidney cancer	0.000271	0.00189	CcSEcCtD
Spironolactone—Pruritus—Sorafenib—kidney cancer	0.00027	0.00189	CcSEcCtD
Spironolactone—Vomiting—Erlotinib—kidney cancer	0.00027	0.00189	CcSEcCtD
Spironolactone—Erythema multiforme—Capecitabine—kidney cancer	0.00027	0.00188	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vincristine—kidney cancer	0.000268	0.00187	CcSEcCtD
Spironolactone—Rash—Erlotinib—kidney cancer	0.000268	0.00187	CcSEcCtD
Spironolactone—Dermatitis—Erlotinib—kidney cancer	0.000267	0.00187	CcSEcCtD
Spironolactone—Headache—Erlotinib—kidney cancer	0.000266	0.00186	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—kidney cancer	0.000263	0.101	CrCbGaD
Spironolactone—Nausea—Vinblastine—kidney cancer	0.000262	0.00183	CcSEcCtD
Spironolactone—Somnolence—Gemcitabine—kidney cancer	0.000262	0.00183	CcSEcCtD
Spironolactone—Nausea—Everolimus—kidney cancer	0.000261	0.00183	CcSEcCtD
Spironolactone—Diarrhoea—Sorafenib—kidney cancer	0.000261	0.00182	CcSEcCtD
Spironolactone—Pruritus—Sunitinib—kidney cancer	0.00026	0.00182	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—kidney cancer	0.000256	0.00179	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—kidney cancer	0.000256	0.0983	CrCbGaD
Spironolactone—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000255	0.00178	CcSEcCtD
Spironolactone—Discomfort—Paclitaxel—kidney cancer	0.000254	0.00178	CcSEcCtD
Spironolactone—Dizziness—Sorafenib—kidney cancer	0.000253	0.00176	CcSEcCtD
Spironolactone—Nausea—Erlotinib—kidney cancer	0.000252	0.00176	CcSEcCtD
Spironolactone—Alopecia—Capecitabine—kidney cancer	0.000252	0.00176	CcSEcCtD
Spironolactone—Diarrhoea—Sunitinib—kidney cancer	0.000251	0.00176	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—kidney cancer	0.00025	0.00174	CcSEcCtD
Spironolactone—Confusional state—Paclitaxel—kidney cancer	0.000249	0.00174	CcSEcCtD
Spironolactone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000247	0.00172	CcSEcCtD
Spironolactone—Body temperature increased—Vincristine—kidney cancer	0.000246	0.00172	CcSEcCtD
Spironolactone—Dizziness—Sunitinib—kidney cancer	0.000243	0.0017	CcSEcCtD
Spironolactone—Feeling abnormal—Gemcitabine—kidney cancer	0.000243	0.0017	CcSEcCtD
Spironolactone—Vomiting—Sorafenib—kidney cancer	0.000243	0.0017	CcSEcCtD
Spironolactone—Thrombocytopenia—Paclitaxel—kidney cancer	0.000242	0.00169	CcSEcCtD
Spironolactone—Rash—Sorafenib—kidney cancer	0.000241	0.00168	CcSEcCtD
Spironolactone—Dermatitis—Sorafenib—kidney cancer	0.000241	0.00168	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000239	0.00167	CcSEcCtD
Spironolactone—Headache—Sorafenib—kidney cancer	0.000239	0.00167	CcSEcCtD
Spironolactone—Muscle spasms—Capecitabine—kidney cancer	0.000239	0.00167	CcSEcCtD
Spironolactone—Diarrhoea—Dactinomycin—kidney cancer	0.000238	0.00166	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—kidney cancer	0.000235	0.00164	CcSEcCtD
Spironolactone—Vomiting—Sunitinib—kidney cancer	0.000234	0.00163	CcSEcCtD
Spironolactone—Body temperature increased—Gemcitabine—kidney cancer	0.000233	0.00163	CcSEcCtD
Spironolactone—Rash—Sunitinib—kidney cancer	0.000232	0.00162	CcSEcCtD
Spironolactone—Dermatitis—Sunitinib—kidney cancer	0.000231	0.00162	CcSEcCtD
Spironolactone—Ill-defined disorder—Capecitabine—kidney cancer	0.00023	0.00161	CcSEcCtD
Spironolactone—Headache—Sunitinib—kidney cancer	0.00023	0.00161	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—kidney cancer	0.000229	0.0016	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—kidney cancer	0.000227	0.00159	CcSEcCtD
Spironolactone—Nausea—Sorafenib—kidney cancer	0.000227	0.00158	CcSEcCtD
Spironolactone—Malaise—Capecitabine—kidney cancer	0.000224	0.00156	CcSEcCtD
Spironolactone—Leukopenia—Capecitabine—kidney cancer	0.000222	0.00155	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—kidney cancer	0.000221	0.00154	CcSEcCtD
Spironolactone—Somnolence—Paclitaxel—kidney cancer	0.000219	0.00153	CcSEcCtD
Spironolactone—Rash—Dactinomycin—kidney cancer	0.000219	0.00153	CcSEcCtD
Spironolactone—Nausea—Sunitinib—kidney cancer	0.000218	0.00152	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000213	0.00149	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—kidney cancer	0.000213	0.00149	CcSEcCtD
Spironolactone—Discomfort—Capecitabine—kidney cancer	0.000209	0.00146	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—kidney cancer	0.000209	0.00146	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—kidney cancer	0.000207	0.00144	CcSEcCtD
Spironolactone—Dizziness—Vincristine—kidney cancer	0.000206	0.00144	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—kidney cancer	0.000205	0.00143	CcSEcCtD
Spironolactone—Confusional state—Capecitabine—kidney cancer	0.000204	0.00143	CcSEcCtD
Spironolactone—Feeling abnormal—Paclitaxel—kidney cancer	0.000203	0.00142	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000203	0.00142	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—kidney cancer	0.000202	0.00141	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—kidney cancer	0.000201	0.00141	CcSEcCtD
Spironolactone—Thrombocytopenia—Capecitabine—kidney cancer	0.000198	0.00139	CcSEcCtD
Spironolactone—Vomiting—Vincristine—kidney cancer	0.000198	0.00138	CcSEcCtD
Spironolactone—Urticaria—Paclitaxel—kidney cancer	0.000196	0.00137	CcSEcCtD
Spironolactone—Rash—Vincristine—kidney cancer	0.000196	0.00137	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—kidney cancer	0.000196	0.00137	CcSEcCtD
Spironolactone—Body temperature increased—Paclitaxel—kidney cancer	0.000195	0.00136	CcSEcCtD
Spironolactone—Headache—Vincristine—kidney cancer	0.000195	0.00136	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—kidney cancer	0.000191	0.00133	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—kidney cancer	0.000187	0.00131	CcSEcCtD
Spironolactone—Rash—Gemcitabine—kidney cancer	0.000186	0.0013	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—kidney cancer	0.000186	0.0013	CcSEcCtD
Spironolactone—Headache—Gemcitabine—kidney cancer	0.000185	0.00129	CcSEcCtD
Spironolactone—Nausea—Vincristine—kidney cancer	0.000185	0.00129	CcSEcCtD
Spironolactone—Hypersensitivity—Paclitaxel—kidney cancer	0.000182	0.00127	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—kidney cancer	0.000175	0.00122	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000175	0.00122	CcSEcCtD
Spironolactone—Pruritus—Paclitaxel—kidney cancer	0.000175	0.00122	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—kidney cancer	0.000174	0.00121	CcSEcCtD
Spironolactone—Diarrhoea—Paclitaxel—kidney cancer	0.000169	0.00118	CcSEcCtD
Spironolactone—Feeling abnormal—Capecitabine—kidney cancer	0.000167	0.00117	CcSEcCtD
Spironolactone—Dizziness—Paclitaxel—kidney cancer	0.000163	0.00114	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—kidney cancer	0.000162	0.00113	CcSEcCtD
Spironolactone—Progesterone—CYP1A1—kidney cancer	0.000162	0.0623	CrCbGaD
Spironolactone—Urticaria—Capecitabine—kidney cancer	0.000161	0.00112	CcSEcCtD
Spironolactone—Body temperature increased—Capecitabine—kidney cancer	0.00016	0.00112	CcSEcCtD
Spironolactone—Vomiting—Paclitaxel—kidney cancer	0.000157	0.0011	CcSEcCtD
Spironolactone—Rash—Paclitaxel—kidney cancer	0.000156	0.00109	CcSEcCtD
Spironolactone—Dermatitis—Paclitaxel—kidney cancer	0.000156	0.00109	CcSEcCtD
Spironolactone—Headache—Paclitaxel—kidney cancer	0.000155	0.00108	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—kidney cancer	0.000154	0.00107	CcSEcCtD
Spironolactone—Testosterone—CYP1A1—kidney cancer	0.000153	0.0589	CrCbGaD
Spironolactone—Hypersensitivity—Capecitabine—kidney cancer	0.000149	0.00104	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—kidney cancer	0.000148	0.00104	CcSEcCtD
Spironolactone—Nausea—Paclitaxel—kidney cancer	0.000147	0.00102	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—kidney cancer	0.000144	0.00101	CcSEcCtD
Spironolactone—Pruritus—Capecitabine—kidney cancer	0.000143	0.001	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—kidney cancer	0.000143	0.001	CcSEcCtD
Spironolactone—Diarrhoea—Capecitabine—kidney cancer	0.000139	0.000968	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—kidney cancer	0.000135	0.00094	CcSEcCtD
Spironolactone—Dizziness—Capecitabine—kidney cancer	0.000134	0.000936	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—kidney cancer	0.000132	0.00092	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000131	0.000912	CcSEcCtD
Spironolactone—Vomiting—Capecitabine—kidney cancer	0.000129	0.0009	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—kidney cancer	0.000128	0.000893	CcSEcCtD
Spironolactone—Rash—Capecitabine—kidney cancer	0.000128	0.000892	CcSEcCtD
Spironolactone—Dermatitis—Capecitabine—kidney cancer	0.000128	0.000891	CcSEcCtD
Spironolactone—Headache—Capecitabine—kidney cancer	0.000127	0.000886	CcSEcCtD
Spironolactone—Nausea—Capecitabine—kidney cancer	0.00012	0.00084	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—kidney cancer	0.000116	0.000811	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000113	0.000787	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—kidney cancer	0.000108	0.000752	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—kidney cancer	0.000106	0.0406	CrCbGaD
Spironolactone—Urticaria—Doxorubicin—kidney cancer	0.000104	0.000725	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—kidney cancer	0.000103	0.000721	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—kidney cancer	9.62e-05	0.000672	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—kidney cancer	9.24e-05	0.000645	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—kidney cancer	8.94e-05	0.000624	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—kidney cancer	8.64e-05	0.000603	CcSEcCtD
Spironolactone—Progesterone—ABCB1—kidney cancer	8.61e-05	0.0331	CrCbGaD
Spironolactone—Vomiting—Doxorubicin—kidney cancer	8.3e-05	0.00058	CcSEcCtD
Spironolactone—Rash—Doxorubicin—kidney cancer	8.23e-05	0.000575	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—kidney cancer	8.23e-05	0.000575	CcSEcCtD
Spironolactone—Headache—Doxorubicin—kidney cancer	8.18e-05	0.000571	CcSEcCtD
Spironolactone—Testosterone—ABCB1—kidney cancer	8.14e-05	0.0313	CrCbGaD
Spironolactone—Nausea—Doxorubicin—kidney cancer	7.76e-05	0.000542	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—SLC5A3—kidney cancer	4e-05	0.000549	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—JUN—kidney cancer	4e-05	0.000549	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PSMD7—kidney cancer	4e-05	0.000548	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.97e-05	0.000545	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.96e-05	0.000544	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.96e-05	0.000543	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—BCHE—kidney cancer	3.96e-05	0.000543	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LDHB—kidney cancer	3.93e-05	0.000538	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.92e-05	0.000538	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ACHE—kidney cancer	3.91e-05	0.000537	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTT1—kidney cancer	3.91e-05	0.000537	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC5A5—kidney cancer	3.91e-05	0.000536	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—kidney cancer	3.86e-05	0.00053	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	3.83e-05	0.000525	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—kidney cancer	3.81e-05	0.000523	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	3.79e-05	0.00052	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC2A1—kidney cancer	3.77e-05	0.000518	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TCEB1—kidney cancer	3.75e-05	0.000515	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TCEB2—kidney cancer	3.75e-05	0.000515	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACY1—kidney cancer	3.74e-05	0.000514	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.74e-05	0.000513	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	3.71e-05	0.000509	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SCARB1—kidney cancer	3.7e-05	0.000508	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS1—kidney cancer	3.67e-05	0.000503	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.66e-05	0.000502	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.66e-05	0.000502	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.66e-05	0.000502	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.66e-05	0.000502	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP2—kidney cancer	3.65e-05	0.0005	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKAP13—kidney cancer	3.65e-05	0.0005	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.61e-05	0.000495	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PSMD7—kidney cancer	3.6e-05	0.000493	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—JUNB—kidney cancer	3.59e-05	0.000492	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	3.57e-05	0.00049	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.53e-05	0.000484	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.51e-05	0.000481	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.5e-05	0.00048	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.44e-05	0.000471	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—BCHE—kidney cancer	3.41e-05	0.000468	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CA9—kidney cancer	3.4e-05	0.000467	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC5A5—kidney cancer	3.37e-05	0.000462	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GRB7—kidney cancer	3.34e-05	0.000458	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.33e-05	0.000457	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.33e-05	0.000456	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EIF4EBP1—kidney cancer	3.28e-05	0.000449	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HSPB1—kidney cancer	3.28e-05	0.000449	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACY1—kidney cancer	3.26e-05	0.000447	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC2A1—kidney cancer	3.25e-05	0.000446	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.24e-05	0.000444	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.19e-05	0.000438	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.19e-05	0.000438	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PDHB—kidney cancer	3.18e-05	0.000437	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—POMC—kidney cancer	3.17e-05	0.000435	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.15e-05	0.000433	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTP1—kidney cancer	3.15e-05	0.000432	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.13e-05	0.000429	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ITPR2—kidney cancer	3.1e-05	0.000425	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.06e-05	0.00042	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RPL14—kidney cancer	3.05e-05	0.000418	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PSMD7—kidney cancer	3.05e-05	0.000418	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CCBL1—kidney cancer	2.99e-05	0.000411	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCB1—kidney cancer	2.98e-05	0.000409	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.96e-05	0.000406	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CDKN2B—kidney cancer	2.92e-05	0.000401	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CRABP1—kidney cancer	2.89e-05	0.000397	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTM1—kidney cancer	2.89e-05	0.000397	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNA1—kidney cancer	2.81e-05	0.000386	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EIF4EBP1—kidney cancer	2.8e-05	0.000384	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HSPB1—kidney cancer	2.8e-05	0.000384	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PDHB—kidney cancer	2.77e-05	0.00038	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.75e-05	0.000377	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1A1—kidney cancer	2.74e-05	0.000376	CbGpPWpGaD
Spironolactone—AR—Gene Expression—JUNB—kidney cancer	2.73e-05	0.000375	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTP1—kidney cancer	2.71e-05	0.000372	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.71e-05	0.000371	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ITPR2—kidney cancer	2.69e-05	0.000369	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.67e-05	0.000366	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CCBL1—kidney cancer	2.61e-05	0.000358	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSC1—kidney cancer	2.6e-05	0.000357	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ANXA1—kidney cancer	2.6e-05	0.000357	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSMD7—kidney cancer	2.6e-05	0.000357	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.6e-05	0.000356	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPAT—kidney cancer	2.6e-05	0.000356	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCB1—kidney cancer	2.57e-05	0.000352	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.56e-05	0.000352	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.54e-05	0.000348	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FLT1—kidney cancer	2.52e-05	0.000345	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTM1—kidney cancer	2.49e-05	0.000342	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.49e-05	0.000341	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HSPB1—kidney cancer	2.49e-05	0.000341	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.48e-05	0.00034	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTT1—kidney cancer	2.45e-05	0.000337	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ACHE—kidney cancer	2.45e-05	0.000337	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APRT—kidney cancer	2.41e-05	0.000331	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FH—kidney cancer	2.41e-05	0.000331	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1A1—kidney cancer	2.36e-05	0.000324	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.36e-05	0.000324	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—kidney cancer	2.35e-05	0.000323	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUNB—kidney cancer	2.33e-05	0.00032	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PAK1—kidney cancer	2.33e-05	0.00032	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SCARB1—kidney cancer	2.32e-05	0.000319	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PSMD7—kidney cancer	2.31e-05	0.000317	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS1—kidney cancer	2.3e-05	0.000315	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPC3—kidney cancer	2.27e-05	0.000311	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPAT—kidney cancer	2.26e-05	0.00031	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GLIPR1—kidney cancer	2.26e-05	0.00031	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PSMD7—kidney cancer	2.25e-05	0.000309	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.25e-05	0.000309	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CDKN2B—kidney cancer	2.23e-05	0.000305	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA2—kidney cancer	2.21e-05	0.000303	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALAD—kidney cancer	2.15e-05	0.000295	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BCHE—kidney cancer	2.14e-05	0.000293	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC5A5—kidney cancer	2.11e-05	0.00029	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APRT—kidney cancer	2.1e-05	0.000288	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FH—kidney cancer	2.1e-05	0.000288	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.1e-05	0.000288	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.1e-05	0.000288	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—JUNB—kidney cancer	2.07e-05	0.000285	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.07e-05	0.000285	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.05e-05	0.000281	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POMC—kidney cancer	2.04e-05	0.00028	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC2A1—kidney cancer	2.04e-05	0.00028	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.03e-05	0.000278	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.98e-05	0.000271	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPC3—kidney cancer	1.98e-05	0.000271	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PGK1—kidney cancer	1.97e-05	0.00027	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.97e-05	0.00027	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.94e-05	0.000267	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.94e-05	0.000266	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.93e-05	0.000265	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LDHB—kidney cancer	1.93e-05	0.000265	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA2—kidney cancer	1.92e-05	0.000264	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.92e-05	0.000264	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—kidney cancer	1.91e-05	0.000262	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF2—kidney cancer	1.91e-05	0.000262	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—kidney cancer	1.9e-05	0.000261	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALAD—kidney cancer	1.87e-05	0.000257	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.86e-05	0.000256	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—kidney cancer	1.86e-05	0.000255	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—kidney cancer	1.84e-05	0.000253	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.83e-05	0.000251	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.83e-05	0.000251	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.83e-05	0.000251	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.81e-05	0.000249	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—kidney cancer	1.79e-05	0.000246	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.79e-05	0.000245	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.77e-05	0.000243	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.77e-05	0.000243	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POMC—kidney cancer	1.76e-05	0.000242	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.73e-05	0.000237	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PGK1—kidney cancer	1.71e-05	0.000235	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A3—kidney cancer	1.71e-05	0.000235	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—kidney cancer	1.7e-05	0.000233	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.69e-05	0.000232	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LDHB—kidney cancer	1.68e-05	0.000231	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA9—kidney cancer	1.67e-05	0.000229	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.63e-05	0.000224	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—kidney cancer	1.63e-05	0.000224	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—kidney cancer	1.61e-05	0.000221	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.6e-05	0.000219	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—kidney cancer	1.56e-05	0.000214	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—kidney cancer	1.52e-05	0.000208	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSC2—kidney cancer	1.51e-05	0.000208	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.51e-05	0.000207	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—kidney cancer	1.48e-05	0.000203	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.47e-05	0.000202	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA9—kidney cancer	1.46e-05	0.0002	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—kidney cancer	1.45e-05	0.000199	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.44e-05	0.000197	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CRABP1—kidney cancer	1.42e-05	0.000195	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—kidney cancer	1.42e-05	0.000195	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—kidney cancer	1.41e-05	0.000193	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.36e-05	0.000186	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.36e-05	0.000186	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—kidney cancer	1.34e-05	0.000184	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—kidney cancer	1.34e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ITPR2—kidney cancer	1.32e-05	0.000181	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—kidney cancer	1.27e-05	0.000175	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—kidney cancer	1.26e-05	0.000172	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.25e-05	0.000171	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CRABP1—kidney cancer	1.24e-05	0.00017	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—kidney cancer	1.23e-05	0.000168	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.22e-05	0.000167	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.22e-05	0.000167	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.21e-05	0.000166	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—kidney cancer	1.21e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACHE—kidney cancer	1.21e-05	0.000165	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—kidney cancer	1.16e-05	0.00016	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ITPR2—kidney cancer	1.15e-05	0.000158	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SCARB1—kidney cancer	1.14e-05	0.000157	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—kidney cancer	1.13e-05	0.000155	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000155	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PSMD7—kidney cancer	1.11e-05	0.000152	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—kidney cancer	1.1e-05	0.000152	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—kidney cancer	1.05e-05	0.000144	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACHE—kidney cancer	1.05e-05	0.000144	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—kidney cancer	1.05e-05	0.000144	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAF1—kidney cancer	1.05e-05	0.000144	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RELA—kidney cancer	1.05e-05	0.000143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—kidney cancer	1.04e-05	0.000142	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.04e-05	0.000142	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—kidney cancer	1.02e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—kidney cancer	1e-05	0.000138	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A1—kidney cancer	1e-05	0.000137	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SCARB1—kidney cancer	9.94e-06	0.000136	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS1—kidney cancer	9.84e-06	0.000135	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.72e-06	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PSMD7—kidney cancer	9.65e-06	0.000132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—kidney cancer	9.62e-06	0.000132	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—kidney cancer	9.41e-06	0.000129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—kidney cancer	9.18e-06	0.000126	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—kidney cancer	9.16e-06	0.000126	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—kidney cancer	9.15e-06	0.000126	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—kidney cancer	9.09e-06	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—kidney cancer	9.04e-06	0.000124	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—kidney cancer	8.87e-06	0.000122	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—kidney cancer	8.86e-06	0.000122	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—kidney cancer	8.81e-06	0.000121	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A1—kidney cancer	8.73e-06	0.00012	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—kidney cancer	8.64e-06	0.000119	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—kidney cancer	8.62e-06	0.000118	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.48e-06	0.000116	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—kidney cancer	8.36e-06	0.000115	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.32e-06	0.000114	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—kidney cancer	8e-06	0.00011	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—kidney cancer	7.91e-06	0.000109	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—kidney cancer	7.68e-06	0.000105	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—kidney cancer	7.68e-06	0.000105	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—kidney cancer	7.57e-06	0.000104	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—kidney cancer	7.36e-06	0.000101	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—kidney cancer	7.28e-06	9.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—kidney cancer	7.28e-06	9.99e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK1—kidney cancer	7.2e-06	9.88e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—kidney cancer	6.8e-06	9.33e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—kidney cancer	6.73e-06	9.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—kidney cancer	6.69e-06	9.18e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—kidney cancer	6.54e-06	8.98e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—kidney cancer	6.34e-06	8.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—kidney cancer	6.25e-06	8.57e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—kidney cancer	6.04e-06	8.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.98e-06	8.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—kidney cancer	5.43e-06	7.45e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—kidney cancer	5.42e-06	7.44e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—kidney cancer	4.73e-06	6.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—kidney cancer	4.33e-06	5.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—kidney cancer	3.78e-06	5.18e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—kidney cancer	3.77e-06	5.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—kidney cancer	3.29e-06	4.51e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.66e-06	3.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—kidney cancer	2.32e-06	3.18e-05	CbGpPWpGaD
